PREPANDRIX INJECTION 3.75mcG

Product Information

Registration Status: Active

PREPANDRIX INJECTION 3.75mcG is approved to be sold in Singapore with effective from 2009-03-24. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN13623P.

This product contains Purified Antigen Fractions Of Inactivated Split Virions - A/Indonesia/05/2005 (H5N1)/Pr8-Ibcdc-Rg2 3.75mcg haemagglutinin/0.25ml in the form of INJECTION, EMULSION. It is approved for INTRAMUSCULAR use.

This product is manufactured by GlaxoSmithKline Biologicals (previously known as Sachsisches Serumwerk Dresden) (for H5N1) in BELGIUM,GlaxoSmithKline Biologicals s.a. (for AS03) in GERMANY, andGlaxoSmithKline Biologicals s.a. (for H5N1; filling site) in UNITED KINGDOM.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Purified Antigen Fractions Of Inactivated Split Virions - A/Indonesia/05/2005 (H5N1)/Pr8-Ibcdc-Rg2


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank